#United States #Provident Healthcare #CPS Infusion #Seven Hills Capital #Boston and New York

CPS Infusion Partners with Seven Hills Capital

Provident Healthcare Partners, a premier player in healthcare investment banking, has officially announced its advisory role for CPS Infusion in a pivotal partnership with Seven Hills Capital. This collaboration is set to enhance CPS Infusion's market presence and service offerings in Georgia's infusion therapy landscape.

Overview of the Partnership

CPS Infusion, known for its commitment to providing high-quality infusion services, operates several facilities across the Greater Atlanta area. By partnering with Seven Hills Capital, the company aims to diversify its therapeutic services and reach new patient demographics. This strategic move is a testament to CPS's commitment to innovation and excellence in patient care.

Dr. Marcus Crawford, Founder and CEO of CPS, expressed profound appreciation for Provident's expertise during this significant transaction. "The dedication and knowledge demonstrated by the Provident team were instrumental in navigating complex negotiations and ensuring a favorable outcome," he noted.

Key Players in the Transaction

The team at Provident, led by Managing Directors Kevin Palamara and Scott Davis, provided insights and guidance throughout the deal. Legal support was also crucial, with Fox Rothschild representing CPS and Bass Berry Sims advising Seven Hills.

Scott Davis highlighted the unique investment opportunity that CPS presents, calling it a formidable match for Seven Hills Capital's objectives. He said, "CPS's unique blend of services requires an equally remarkable investor, and we believe the partnership with Seven Hills will yield significant developments for the platform moving forward."

About CPS Infusion

CPS Infusion prides itself on delivering infusion therapies in a patient-centric environment tailored for individuals battling chronic ailments. The organization emphasizes complex biologic medications, ensuring that patients receive the best possible care while comfortably receiving treatment. Their facilities are designed to provide a welcoming atmosphere conducive to healing and recovery.

The services offered include a range of complex therapies, demonstrating the organization's expertise and commitment to improving patient outcomes.

About Seven Hills Capital

Founded in 2016 and headquartered in Nashville, Tennessee, Seven Hills Capital focuses on reacting to healthcare needs through strategic investments. The firm operates with a unique mindset, emphasizing value creation within niche healthcare markets. Their recent inaugural fund closure at $125 million underscores their robust position in the investment landscape, particularly in lower-middle-market healthcare.

Seven Hills Capital's commitment extends to aligning with practitioners and management teams who are dedicated to building innovative and resilient business models, catering especially to underserved areas in healthcare.

Provident Healthcare Partners' Role

Provident Healthcare Partners distinguishes itself through its extensive knowledge of healthcare M&A processes and market sectors. Their expertise in infusion care and healthcare investment advisory allows them to offer specialized guidance tailored to the needs of their clients.

Their successful track record, including the recent advisory for CPS Infusion, illustrates their pivotal role in facilitating crucial healthcare partnerships and expansions.

For more information about CPS Infusion, visit cpsinfusion.com, and for insights on Seven Hills Capital, check out 7hillscap.com. To learn more about Provident Healthcare Partners, explore providenthp.com.

Conclusion

In conclusion, the partnership between CPS Infusion and Seven Hills Capital, orchestrated by Provident Healthcare Partners, marks a significant milestone in the healthcare domain. This strategic alignment is anticipated to yield advancements in service delivery and therapeutic diversification, ultimately benefiting patients across Georgia. By understanding the challenges within the healthcare market and the importance of targeted investments, stakeholders can look forward to further developments within this exciting venture.